Industry News
Research, Science & Manufacturer Updates
Australian investigators tested the ability of intravenous immune globulin to protect against potential pandemic influenza virus in outbred ferrets, which are naturally susceptible to human influenza viruses and considered a relevant small animal model of human influenza infection.
Results of a new clinical trial show that the bacillus Calmette-Guerin vaccine could permanently reverse advanced type 1 diabetes in mice.
New research suggests a certain strain of influenza virus predisposes mice to developing pathologies that mimic those seen in Parkinson’s disease.
A new study conducted by the Centers for Disease Control and Prevention shows that during the years 2010 through 2014, the influenza vaccine reduced the risk of flu-associated death by half among children with underlying high-risk medical conditions and by nearly two-thirds among healthy children.
The U.S. Food and Drug Administration has approved Novo Nordisk’s Rebinyn (coagulation factorIX [recombinant], glycopegylated) to treat hemophilia B in adults and children.
Human and recombinant apolipoprotein A-I (apoA-I) is the primary functional component of high-density lipoprotein, and has been shown to increase cholesterol efflux capacity and to regress atherosclerotic disease in animal and clinical studies.
A Phase I clinical trial has shown that NGP 555, a drug developed to treat and prevent Alzheimer’s disease, was safe and well-tolerated with dose-dependent plasma exposure.
Study results from the division of oncology at University Hospital Basel in Switzerland show that patients treated with PD-1/PD-L1 checkpoint inhibitors may be at an increased risk for adverse events after receiving the seasonal influenza vaccination.
The U.S. Department of Health and Human Services has launched anew page on its website that highlights regulatory and administrative actions it is taking to support a patient-centered healthcare system.
A new study shows newborns of pregnant women who have gotten their pertussis booster vaccine are far less likely to get
the disease than other babies.
Connected Care is a new educational initiative to raise awareness of the benefits of chronic care management (CCM)services for Medicare beneficiaries with multiple chronic conditions.
A new vaccine to protect against rotavirus has been developed by Serum Institute of India.